Author:
Sata Naohiro,Koizumi Masaru,Tsukahara Munetoshi,Yoshizawa Koji,Kurihara Katsumi,Nagai Hideo
Publisher
The Japanese Society of Strategies for Cancer Research and Therapy
Subject
Pharmacology (medical),Cancer Research,Oncology
Reference33 articles.
1. Andre, T., Balosso, J. and Louvet, C. (2000) Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility study. Int J Radiat Oncol Biol Phys. 46 (4): 903-911
2. Andre, T., Balosso, J., Louvet, C., Hannoun, L., Houry, S., Huguier, M., Colonna, M., Lotz, J. P., De Gramont, A., Bellaiche, A., Parc, R, Touboul, E. and Izrael, V. (2000) Combined radiotherapy and chemotherapy (cisplatin and 5-FU) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility study. Int J Radiat Oncol Biol Phys 46: 903-911,
3. Andre, T., Lotz, J. P., Azzouzi, K., Houry, S., Hannoun, L., See, J., Esteso, A., Avenin, D. and Izrael, V. (1996) Phase II trial of 5-fluorouracil and cisplatin for treatment of advanced pancreatic adenocarcinoma. Ann Oncol 7: 173-178.
4. Andre, T., Lotz, J. P. and Azzouzi, K. (1996) Phase II trial of 5-fluorouracil and cisplatin for treatment of advanced pancreatic adenocarcinoma. Ann Oncol. 7 (2): 173-178.
5. Burch, P. A., Block, M. and Schroeder, G (2000) Phase III evaluation of octreotide versus chemotherapy with 5-fluorouracil or 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer: a North Central Cancer Treatment Group study. Clin Cancer Res. 6 (9): 3486-3492.